- Approval Id
- 75b6ade1bd2a5cb3
- Drug Name
- DUSPATALIN RETARD CAPSULE 200 MG
- Product Name
- DUSPATALIN RETARD CAPSULE 200 MG
- Approval Number
- SIN07666P
- Approval Date
- 1994-03-10
- Registrant
- ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
- Licence Holder
- ABBOTT LABORATORIES (SINGAPORE) PRIVATE LIMITED
- Drug Type
- Therapeutic
- Forensic Classification
- PHARMACY ONLY MEDICINES
- Dosage Form
- CAPSULE
- Dosage
- <p><strong>Dosage and administration</strong><br>
<u>Adults</u><br>
Take one capsule twice daily, one in the morning and one in the evening.<br>
The capsules should be swallowed with a sufficient amount of water (at least 100 ml of water). They should not be chewed because the coating is intended to ensure a prolonged release mechanism.</p>
<p>Treatment Duration<br>
Symptom relief occurs after a minimum of 2 to 4 weeks of treatment and greater effects can be observed after a prolonged therapy of 6 to 8 weeks.<br>
Always take Duspatalin retard exactly as your doctor has prescribed. If you have any questions, check with your doctor or pharmacist.<br>
In case of one or more dose(s) is (are) missed, you should continue with the next dose as prescribed; the missed dose(s) is (are) not to be taken in addition to the regular dose.</p>
<p><u>Paediatric Population</u><br>
Duspatalin retard 200 mg capsules are not recommended for use in children and adolescents below 18, due to insufficient data on safety and efficacy.</p>
<p><u>Special Population</u><br>
No posology studies in elderly, renal and/or hepatic impaired patients have been performed. However, no specific risk for elderly, renal and/or hepatic impaired patients could be identified from available post-marketing data. No dosage adjustment is deemed necessary in these patients.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications</strong><br>
Symptomatic treatment of abdominal pain and cramps, bowel disturbances and intestinal discomfort related to irritable bowel syndrome.<br>
Treatment of gastro-intestinal spasm secondary to organ diseases.</p>
- Contraindications
- <p><strong>Contraindications</strong><br>
Do not take this medicine if you are allergic (Hypersensitivity) to the active substance or to any of the excipients.</p>
- Atc Code
- A03AA04
- Atc Item Name
- mebeverine
- Pharma Manufacturer Name
- ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
- Company Detail Path
- /organization/abbott-laboratories-singapore-private-limited
